-
Signature
-
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
-
Issuer symbol
-
EXAS
-
Transactions as of
-
14 Feb 2024
-
Net transactions value
-
-$887,327
-
Form type
-
4
-
Filing time
-
16 Feb 2024, 18:22:23 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EXAS |
Common Stock |
Award |
$21,284 |
+709 |
+0.06% |
$30.02 |
1,208,015 |
01 May 2023 |
Direct |
F1 |
| transaction |
EXAS |
Common Stock |
Options Exercise |
$0 |
+31,133 |
+2.6% |
$0.000000 |
1,239,148 |
14 Feb 2024 |
Direct |
F2 |
| transaction |
EXAS |
Common Stock |
Sale |
$908,611 |
-14,791 |
-1.2% |
$61.43 |
1,224,357 |
15 Feb 2024 |
Direct |
F3, F4 |
| holding |
EXAS |
Common Stock |
|
|
|
|
|
27,600 |
14 Feb 2024 |
Held in 401(k) Plan |
|
| holding |
EXAS |
Common Stock |
|
|
|
|
|
21,730 |
14 Feb 2024 |
Held in Grantor Retained Annuity Trust |
|
| holding |
EXAS |
Common Stock |
|
|
|
|
|
21,730 |
14 Feb 2024 |
Held in Grantor Retained Annuity Trust |
|
| holding |
EXAS |
Common Stock |
|
|
|
|
|
21,729 |
14 Feb 2024 |
Held in Grantor Retained Annuity Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EXAS |
Restricted Stock Units |
Options Exercise |
$0 |
-31,133 |
-100% |
$0.000000* |
0 |
14 Feb 2024 |
Common Stock |
31,133 |
|
Direct |
F5, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: